Its treated the same way as many experimental compounds: allowed for research use only , not for human ingestion
Usually administered monthly or every 23 weeks, depending on the condition
The investment in a complete cycle generally proves worthwhile for appropriate injuries
Retatrutides three arms, GLP-1, GIP, and glucagon, all engage at low doses
Stability in the specific capsule product you are using is rarely independently verified
Dosage and administration Typical protocols in the literature and clinical practice use subcutaneous injection , often run in a loading-then-maintenance pattern: a higher loading dose over the first 46 weeks, then a lower maintenance dose